Concepedia

Tomáš Cihlář

TC

Statistics

Publications

149

Citations

21.6K

H-Index

63

Active since

1992

Affiliations

Gilead Sciences (United States)(Current)

University of North Carolina at Chapel Hill

Czech Academy of Sciences, Institute of Organic Chemistry and Biochemistry

The University of Texas Medical Branch at Galveston

Vanderbilt University Medical Center

Tomáš Cihlář is an author at Gilead Sciences (United States) specializing in antiviral therapy, antiviral pharmacology, and molecular virology.

ORCID

Publications per year

1992–2025

149

Publications

149

Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV

Timothy P. Sheahan, Amy Sims, Sarah R. Leist et al. · Nature Communications · 2020 · 1.8K citations · Full text

, , +12

Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses

Timothy P. Sheahan, Amy Sims, Rachel L. Graham et al. · Science Translational Medicine · 2017 · 1.6K citations · Full text

, , +14

Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys

Travis K. Warren, Robert Jordan, Michael K. Lo et al. · Nature · 2016 · 1.6K citations · Full text

, , +17

Coronavirus Susceptibility to the Antiviral Remdesivir (GS-5734) Is Mediated by the Viral Polymerase and the Proofreading Exoribonuclease

Maria L. Agostini, Erica L. Andres, Amy Sims et al. · mBio · 2018 · 1.5K citations · Full text

, , +16

Prophylactic and therapeutic remdesivir (GS-5734) treatment in the rhesus macaque model of MERS-CoV infection

Emmie de Wit, Friederike Feldmann, Jacqueline Cronin et al. · Proceedings of the National Academy of Sciences · 2020 · 946 citations · Full text

, , +17

1–5 of 149